Tenet Healthcare (THC) Stock Forecast & Price Target

Compare

963 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

THC Analyst Ratings

Strong Buy

13 Buy

0 Hold

0 Sell

Based on 13 analysts giving stock ratings to

Tenet

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

THC Stock 12 Month Forecast

Average Price Target

$263.23

▲(15.64% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is $263.23 with a high forecast of $288.00 and a low forecast of $240.00. The average price target represents a 15.64% change from the last price of $227.63.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"125":"$125","166":"$166","207":"$207","248":"$248","289":"$289"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":288,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$288.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":263.23,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$263.23</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":240,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$240.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[125,166,207,248,289],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,239.18769230769232,243.25538461538463,247.32307692307694,251.39076923076922,255.45846153846153,259.5261538461539,263.59384615384613,267.66153846153844,271.72923076923075,275.79692307692306,279.8646153846154,283.9323076923077,{"y":288,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,237.2823076923077,239.4446153846154,241.6069230769231,243.76923076923077,245.93153846153848,248.09384615384616,250.25615384615386,252.41846153846154,254.58076923076925,256.74307692307696,258.9053846153846,261.0676923076923,{"y":263.23,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,235.12,235.4953846153846,235.87076923076924,236.24615384615385,236.62153846153848,236.99692307692308,237.3723076923077,237.74769230769232,238.12307692307692,238.49846153846153,238.87384615384616,239.24923076923076,239.6246153846154,{"y":240,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":126.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":145.29,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170.12,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":177.43,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.35,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":201.34,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 44,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":206.49,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.13,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.72,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":188.03,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.12,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$288.00

Average Price Target$263.23

Lowest Price Target$240.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ann Hynes

Mizuho Securities

$235→$265

Buy

16.42%

Upside

Reiterated

03/12/26

Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho

Jason Cassorla

Guggenheim

$271→$283

Buy

24.32%

Upside

Reiterated

03/12/26

Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC)

Benjamin Rossi

J.P. Morgan

$280

Buy

23.01%

Upside

Reiterated

03/11/26

Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)

David S Macdonald

Truist Financial

$240→$270

Buy

18.61%

Upside

Reiterated

02/17/26

Truist Financial Keeps Their Buy Rating on Tenet Healthcare (THC)

Ben Hendrix

RBC Capital

$277

Buy

21.69%

Upside

Reiterated

02/17/26

RBC Capital Keeps Their Buy Rating on Tenet Healthcare (THC)

Stephen Baxter

Wells Fargo

$229→$265

Buy

16.42%

Upside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tenet Healthcare (NYSE: THC) and Pacific Biosciences (NASDAQ: PACB)

Andrew Mok CFA

Barclays

$240→$257

Buy

12.90%

Upside

Reiterated

02/13/26

A.J. Rice

UBS

$260→$288

Buy

26.52%

Upside

Reiterated

02/12/26

Tenet Healthcare price target raised to $288 from $260 at UBSTenet Healthcare price target raised to $288 from $260 at UBS

Craig Hettenbach

Morgan Stanley

$247→$260

Buy

14.22%

Upside

Reiterated

02/12/26

Tenet Healthcare price target raised to $260 from $247 at Morgan StanleyTenet Healthcare price target raised to $260 from $247 at Morgan Stanley

Matthew Gillmor CFA

KeyBanc

$225→$250

Buy

9.83%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Tenet Healthcare (NYSE: THC) and Stoke Therapeutics (NASDAQ: STOK)

Ryan Langston

TD Cowen

$230→$242

Buy

6.31%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Tenet Healthcare (NYSE: THC)

Kevin Fischbeck

Bank of America Securities

$240

Buy

5.43%

Upside

Reiterated

02/11/26

Tenet Healthcare (THC) Gets a Buy from Bank of America Securities

Sarah James

Cantor Fitzgerald

$245

Buy

7.63%

Upside

Reiterated

02/11/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Neurocrine (NASDAQ: NBIX)

Brian Tanquilut

Jefferies

$250

Buy

9.83%

Upside

Reiterated

10/31/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (NYSE: BFLY), Bausch Health Companies (NYSE: BHC) and Tenet Healthcare (NYSE: THC)

John Ransom

Raymond James

$200→$250

Buy

9.83%

Upside

Reiterated

10/29/25

Tenet Healthcare: Strong Performance and Positive Outlook Drive Buy Rating

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ann Hynes

Mizuho Securities

$235→$265

Buy

16.42%

Upside

Reiterated

03/12/26

Tenet Healthcare price target raised to $265 from $235 at MizuhoTenet Healthcare price target raised to $265 from $235 at Mizuho

Jason Cassorla

Guggenheim

$271→$283

Buy

24.32%

Upside

Reiterated

03/12/26

Guggenheim Keeps Their Buy Rating on Tenet Healthcare (THC)

Benjamin Rossi

J.P. Morgan

$280

Buy

23.01%

Upside

Reiterated

03/11/26

Analysts' Top Healthcare Picks: BridgeBio Pharma (BBIO), Tenet Healthcare (THC)

David S Macdonald

Truist Financial

$240→$270

Buy

18.61%

Upside

Reiterated

02/17/26

Truist Financial Keeps Their Buy Rating on Tenet Healthcare (THC)

Ben Hendrix

RBC Capital

$277

Buy

21.69%

Upside

Reiterated

02/17/26

RBC Capital Keeps Their Buy Rating on Tenet Healthcare (THC)

Stephen Baxter

Wells Fargo

$229→$265

Buy

16.42%

Upside

Reiterated

02/13/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tenet Healthcare (NYSE: THC) and Pacific Biosciences (NASDAQ: PACB)

Andrew Mok CFA

Barclays

$240→$257

Buy

12.90%

Upside

Reiterated

02/13/26

A.J. Rice

UBS

$260→$288

Buy

26.52%

Upside

Reiterated

02/12/26

Tenet Healthcare price target raised to $288 from $260 at UBSTenet Healthcare price target raised to $288 from $260 at UBS

Craig Hettenbach

Morgan Stanley

$247→$260

Buy

14.22%

Upside

Reiterated

02/12/26

Tenet Healthcare price target raised to $260 from $247 at Morgan StanleyTenet Healthcare price target raised to $260 from $247 at Morgan Stanley

Matthew Gillmor CFA

KeyBanc

$225→$250

Buy

9.83%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: Humana (NYSE: HUM), Tenet Healthcare (NYSE: THC) and Stoke Therapeutics (NASDAQ: STOK)

Ryan Langston

TD Cowen

$230→$242

Buy

6.31%

Upside

Reiterated

02/12/26

Analysts Offer Insights on Healthcare Companies: CSL (Other OTC: CMXHF) and Tenet Healthcare (NYSE: THC)

Kevin Fischbeck

Bank of America Securities

$240

Buy

5.43%

Upside

Reiterated

02/11/26

Tenet Healthcare (THC) Gets a Buy from Bank of America Securities

Sarah James

Cantor Fitzgerald

$245

Buy

7.63%

Upside

Reiterated

02/11/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Neurocrine (NASDAQ: NBIX)

Brian Tanquilut

Jefferies

$250

Buy

9.83%

Upside

Reiterated

10/31/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Butterfly Network (NYSE: BFLY), Bausch Health Companies (NYSE: BHC) and Tenet Healthcare (NYSE: THC)

John Ransom

Raymond James

$200→$250

Buy

9.83%

Upside

Reiterated

10/29/25

Tenet Healthcare: Strong Performance and Positive Outlook Drive Buy Rating

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months

xxx

Success Rate

15/20 ratings generated profit

Average Return

+14.47%

reiterated a xxx

rating 28 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +14.47% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

24/26 ratings generated profit

Average Return

+36.55%

reiterated a buy rating 28 days ago

Copying David S Macdonald's trades and holding each position for 1 Year would result in 92.31% of your transactions generating a profit, with an average return of +36.55% per trade.

2 Years

xxx

Success Rate

26/26 ratings generated profit

Average Return

+86.33%

reiterated a xxx

rating 28 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +86.33% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, THC has received 34 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. THC average Analyst price target in the past 3 months is 263.23.

Each month's total comprises the sum of three months' worth of ratings.

THC Financial Forecast

THC Earnings Forecast

Next quarter’s earnings estimate for THC is $4.16 with a range of $3.08 to $4.66. The previous quarter’s EPS was $4.70. THC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.

THC Sales Forecast

Next quarter’s sales forecast for THC is $5.40B with a range of $5.35B to $5.45B. The previous quarter’s sales results were $5.53B. THC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year THC has Performed in-line its overall industry.

THC Stock Forecast FAQ

What is THC’s average 12-month price target, according to analysts?

Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 263.23.

What is THC’s upside potential, based on the analysts’ average price target?

Tenet Healthcare has 15.64% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is THC a Buy, Sell or Hold?

Tenet Healthcare has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.

What is Tenet Healthcare’s price target?

The average price target for Tenet Healthcare is 263.23. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $288.00 ,the lowest forecast is $240.00. The average price target represents 15.64% Increase from the current price of $227.63.

What do analysts say about Tenet Healthcare?

Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of THC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Tenet Healthcare (THC) Stock Forecast & Price Target

THC Analyst Ratings

THC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tenet Healthcare

THC Analyst Recommendation Trends

THC Financial Forecast

THC Earnings Forecast

THC Sales Forecast

THC Stock Forecast FAQ

Detailed List of Analyst Forecasts